World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02926534
Date of registration: 03/10/2016
Prospective Registration: No
Primary sponsor: Kazakhstan Academy of Preventive Medicine
Public title: Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan
Scientific title: A Cross-sectional Study of the Socio-demographic and Other Determinants of Chronic Obstructive Pulmonary Disease (COPD) Among Those Who Smoke, Quit Smoking and Never-smoking Cigarettes
Date of first enrolment: September 2016
Target sample size: 900
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02926534
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
Kazakhstan
Contacts
Name:     Almaz T Sharman, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Kazakhstan Academy of Preventive Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- =10 pack-year smoking history (for smokers and ex-smokers)

- less than 100 cigarettes in lifetime (for never-smokers)

- be able to provide informed consent

Exclusion Criteria:

- be pregnant

- has a fever (370C or higher) at the time of the visit and during the last two weeks
preceding the visit

- be legally incapable

- chronic infectious and non-infectious lung disease except asthma (eg, pulmonary
fibrosis, bronchiectasis, cystic fibrosis, tuberculosis, and others.)

- resection of at least one lobe (or performing procedures to reduce lung volume)

- any cancer and receiving a course of radiation and/or chemotherapy at the time of the
visit;

- suspected lung cancer (presence of significant lung neoplasm)

- presence of metal in the chest

- ophthalmic surgery within the last 12 months prior to the visit

- myocardial infarction or other form of acute or chronic coronary insufficiency,
cardiac arrhythmias diagnosed of at least 6 months prior to the visit

- myocardial infarction or other form of acute or chronic coronary insufficiency,
cardiac arrhythmias with which an individual regularly receives medication

- Severely elevated blood pressure (equal to or greater than a systolic 180 or diastolic
of 100)

- history of cerebrovascular accidents

- thoracic or abdominal surgery within the last 6 months

- contraindications to use salbutamol or its analogues

- CT scan or other research using ionizing radiation within the last 6 months



Age minimum: 35 Years
Age maximum: 59 Years
Gender: All
Health Condition(s) or Problem(s) studied
Chronic Obstructive Pulmonary Disease (COPD)
Intervention(s)
Primary Outcome(s)
Evidence of chronic obstructive pulmonary disease [Time Frame: up to 1 week]
Secondary Outcome(s)
COPD CT score [Time Frame: up to 2 weeks]
Presence of metabolic syndrome [Time Frame: up to 1 week]
Comorbidities of COPD [Time Frame: up to 1 week]
Results of 6-minute walking test [Time Frame: up to 1 week]
10 year risk of fatal CVD [Time Frame: up to 1 week]
Presence of an electrocardiogram abnormality [Time Frame: up to 1 week]
Airflow obstruction through lung function test [Time Frame: up to 1 week]
COPD assessment test (CAT) score [Time Frame: up to 1 week]
Secondary ID(s)
IIS.PMI.2016.001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Synergy Research Group Kazakhstan
HealthCity LLP
Philip Morris International
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history